TEOSYAL® PURESENSE REDENSITY I (2x1ml)

Product Overview: TEOSYAL® PURESENSE REDENSITY I (2x1ml)

TEOSYAL® PURESENSE REDENSITY I is a sterile, non-pyrogenic, viscoelastic gel specifically formulated for skin revitalization and redensification. It combines non-crosslinked hyaluronic acid (15mg/ml) with a unique, patented Dermo-Restructuring Complex comprising 8 amino acids, 3 antioxidants, 2 minerals, and Vitamin B6. The formulation also includes 0.3% lidocaine hydrochloride for enhanced patient comfort during the procedure. Manufactured by Teoxane Laboratories (Geneva, Switzerland), this product aims to nourish the skin from within, improve hydration, and restore density for a more radiant complexion.

It is indicated for improving the quality of skin exhibiting signs of aging such as fine lines, dullness, and loss of elasticity, particularly on the face, neck, and décolleté.

Note: This medical device should only be administered by qualified healthcare professionals experienced in skin revitalization techniques.

Mechanism of Action and Properties

TEOSYAL® PURESENSE REDENSITY I works through a dual mechanism. The non-crosslinked hyaluronic acid component provides immediate, deep hydration by attracting and retaining water molecules within the dermis. Concurrently, the Dermo-Restructuring Complex delivers essential nutrients directly to the skin. These components (including key amino acids like Glycine, Lysine, Threonine, Proline; antioxidants like Glutathione; minerals like Zinc and Copper; and Vitamin B6) are selected for their known roles in supporting dermal structure, collagen synthesis, cellular regeneration, and protection against oxidative stress.

The inclusion of lidocaine minimizes discomfort associated with the microinjections used during administration.

This treatment focuses on improving overall skin health and quality rather than providing significant volume augmentation.

Indications and Treatment Protocol

TEOSYAL® PURESENSE REDENSITY I is indicated for individuals seeking to improve skin quality parameters such as:

• Skin hydration
• Skin density and firmness
• Skin texture and smoothness
• Skin radiance and luminosity
• Fine lines (especially in dynamic areas or thin skin)

Common treatment areas include the face, neck, and décolleté. Optimal results are typically achieved through a multi-session protocol, often involving an initial series of treatments spaced several weeks apart, followed by maintenance sessions as determined by the practitioner based on patient response and desired outcome.

Administration involves microinjections into the superficial dermis using appropriate techniques.

Expected Outcomes

Following a recommended treatment course, anticipated outcomes include:

• Visibly improved skin hydration and plumpness
• Enhanced skin density and suppleness
• Increased skin radiance and a more even complexion
• Softening of fine lines and improved overall texture
• Strengthened skin structure and resilience

Potential Adverse Events

As with any injectable procedure, patients may experience temporary reactions primarily related to the injections themselves. Practitioners should advise patients on potential side effects:

• Common Reactions (Typically Mild and Transient): Small red spots (petechiae), erythema (redness), mild swelling or bruising at injection points, slight itching or tenderness. These generally resolve within a few hours to a few days.
• Less Common/Rare Reactions: Persistent discoloration, inflammation, infection, hypersensitivity reactions (potentially related to HA or complex components, though rare), nodule formation.

Patients should be instructed to report any persistent, severe, or concerning reactions to their practitioner promptly.

Storage Conditions

Store between 2°C and 25°C, protected from light and freezing. Ensure the packaging is intact before use.

Disclaimer: This overview provides general information. Healthcare professionals must consult the full product guidelines supplied with TEOSYAL® PURESENSE REDENSITY I for comprehensive details regarding indications, contraindications, warnings, precautions, administration techniques, and potential adverse events before using the product.